Search by Drug Name or NDC

    NDC 45737-0250-16 BIO-RYTUSS 2; 10; 5 mg/5mL; mg/5mL; mg/5mL Details

    BIO-RYTUSS 2; 10; 5 mg/5mL; mg/5mL; mg/5mL

    BIO-RYTUSS is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Advanced Generic Corporation. The primary component is CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 45737-0250
    Product ID 45737-250_42971dd8-e7b7-4696-8082-158e4ee51e4e
    Associated GPIs 43995803120905
    GCN Sequence Number 047004
    GCN Sequence Number Description chlorpheniramine/phenyleph/DM LIQUID 2-5-10MG/5 ORAL
    HIC3 B3R
    HIC3 Description NON-OPIOID ANTITUS-1ST GEN.ANTIHISTAMINE-DECONGEST
    GCN 85914
    HICL Sequence Number 000375
    HICL Sequence Number Description CHLORPHENIRAMINE MALEATE/PHENYLEPHRINE HCL/DEXTROMETHORPHAN
    Brand/Generic Generic
    Proprietary Name BIO-RYTUSS
    Proprietary Name Suffix n/a
    Non-Proprietary Name CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 2; 10; 5
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Advanced Generic Corporation
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Rece
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 45737-0250-16 (45737025016)

    NDC Package Code 45737-250-16
    Billing NDC 45737025016
    Package 473 mL in 1 BOTTLE (45737-250-16)
    Marketing Start Date 2012-08-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL e48e46e3-d3fa-4b25-8b07-bbecc4f0b64b Details

    Revised: 12/2020